BROADWOOD CAPITAL INC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001278387

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedConsumer TiltBuy & Hold how tags are computed

Q3 2026 · 6 positions · Total reported value $1.56B · Top-10 concentration 100.0% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, BROADWOOD CAPITAL INC disclosed 6 equity positions with a combined reported value of $1.56B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / Buy & Hold.

The largest disclosed positions as of Q3 2026 were MNST ($674.87M), STAA ($364.56M), AXON ($293.02M). By sector, the heaviest allocations are Consumer Staples 43.3%, Health Care 29.4%. Versus the prior quarter, allocation shifted toward Consumer Staples (+2.6pp), Other (+1.0pp) and away from Industrials (-1.5pp), Health Care (-2.1pp).

Versus the prior quarter, BROADWOOD CAPITAL INC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest BROADWOOD CAPITAL INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-04-27 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-27 Buy Insight Molecular Diagnostics Inc. 250,923 $3.64 SEC filing
2026-04-24 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-24 Buy Insight Molecular Diagnostics Inc. 38,880 $3.53 SEC filing
2026-04-23 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-23 Buy Insight Molecular Diagnostics Inc. 280,381 $3.50 SEC filing
2026-04-20 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-20 Buy Insight Molecular Diagnostics Inc. 40,690 $3.88 SEC filing

All insider transactions →

Fund Profile

Broadwood Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 6 US equity positions with a combined value of $1.91B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73853 (status: Approved), registered 2012-03-27
  • Regulatory AUM (Form ADV): $1.71B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: broadwoodcapital.com

Portfolio Structure

  • 6 positions · $1.91B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MNST (MONSTER BEVERAGE CORP NEW) at 40.7%
  • Average position size: $318.86M

Sector Tilt

  • Consumer Staples 40.7%
  • Health Care 31.5%
  • Industrials 20.3%
  • (classified holdings cover 93% of value)

Quarterly Activity

  • Q2 2026: 1 added
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund increased its largest holding (MNST) by 100% QoQ, suggesting bullish conviction in consumer staples, while trimming positions in health care (IMDX) and industrials (AXON) modestly, indicating a selective tilt toward growth/defensive sectors. 2. Key moves: Only MNST was added (shares +100%, weight +2.61%); no positions were reduced (action field shows no "Reduce"). Other holdings were held constant. 3. Portfolio structure: Active (concentrated top-10 holdings, 97% of AUM); sector bias toward consumer staples (43%) and health care (26%); moderate risk appetite (high MNST exposure, biotech/industrial diversification). 4. Per-holding one-liner: - MNST: Monster Beverage (energy drinks, Consumer Staples). - STAA: Staar Surgical (ophthalmic devices, Health Care). - AXON: Axon Enterprise (law enforcement tech, Industrials). - IWM: iShares Russell 2000 ETF (small-cap U.S. stocks, unverified benchmark). - LCTX: Lineage Cell Therapeutics (stem cell therapy, Health Care). - IMDX: Insight Molecular Diagnostics (genetic testing, Health Care). 5. Style summary: Concentrated, actively managed fund with a bullish consumer staples tilt and selective health care/industrial exposure.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:31

Sector Allocation

Health Care 29.4%
Industrials 18.8%
Other 8.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 16.21M $674.87M 43.34%
43.34%
Add
2 16.12M $364.56M 23.41%
23.41%
Hold
3 693.50K $293.02M 18.82%
18.82%
Hold
4 474.92K $131.98M 8.47%
8.47%
Hold
5 49.56M $47.37M 3.04%
3.04%
Hold
6 12.68M $45.54M 2.92%
2.92%
Hold

FAQ

What did BROADWOOD CAPITAL INC buy in 2026-Q3?

In its 2026-Q3 13F filing, BROADWOOD CAPITAL INC reported 6 equity positions worth $1.56B in aggregate; its largest disclosed positions were MNST ($674.87M), STAA ($364.56M), AXON ($293.02M).

How large is BROADWOOD CAPITAL INC's portfolio?

BROADWOOD CAPITAL INC reported $1.56B of long equity holdings across 6 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.

What is BROADWOOD CAPITAL INC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/broadwood-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →